BREAKING NEWS
With impact player, it is getting difficult each and every day: Pant
McGurk, Stubbs rock as DC beat MI by 10 runs
BJP drops Poonam Mahajan, picks 26/11 prosecutor Ujjwal Nikam from Mumbai North Central seat
Prabhas, Deepika’s ‘Kalki 2898-AD’ gets new release date
Delhi Capitals post 257/4 against Mumbai Indians
Three women from India killed in US car crash; their Gujarat village holds prayer meeting
Congress accuses CPI(M) of hijacking poll machinery to bring down polling percentage
IPL betting racket busted; three men held, search on for another
Kejriwal continuing as CM even after arrest puts political interest over national interest, says Delhi HC
Firing outside Salman Khan’s home: Lookout circular issued against Anmol Bishnoi
Pune court asks police to probe bribery allegations against IT major Cognizant
Archery WC: India women’s compound team wins gold
IPL 2024: ‘Cricket is turning into baseball’, says Sam Curran after PBKS’ world record run chase
‘Taarak Mehta Ka Ooltah Chashmah’ actor Gurucharan Singh missing
Congress to discuss candidates for Amethi, Raebareli seats on Saturday
Dr Reddy’s launches generic version of Plaquenil in US
Team Udayavani, Jul 11, 2018, 4:39 PM IST
New Delhi: Dr Reddy’s Laboratories today announced the launch of generic version of Plaquenil, used to treat malaria, lupus erythematosus, and rheumatoid arthritis, in the US.
The launch follows approval of Hydroxychloroquine Sulfate tablets, a therapeutic equivalent generic version of Plaquenil, by the US Food and Drug Administration (USFDA), Dr Reddy’s Laboratories said in a BSE filing.
Quoting IMS Health data, Dr Reddy’s Laboratories the Plaquenil brand and generic had US sales of approximately USD 215 million for the most recent twelve months ending in May 2018.
Dr Reddy’s said its product Hydroxychloroquine Sulfate tablets are available in 200 mg tablets in the bottle count sizes of 100 and 500.
Plaquenil is a trademark of Concordia International Corp.
Shares of Dr Reddy’s Laboratories were trading at Rs 2,293.95 apiece, down 1.11 per cent from the previous close on the BSE.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Pune court asks police to probe bribery allegations against IT major Cognizant
Patanjali Foods to evaluate proposal to buy Patanjali Ayurved’s non-food business
Nifty, Sensex rally for 6th day running on firm Asian peers; Tech Mahindra jumps over 12%
IndiGo, Air India plan to purchase up to 170 wide-body planes in little over a year
Kotak Mahindra Bank shares tank 13%; mcap erodes by Rs 37,721 crore post RBI action
MUST WATCH
Latest Additions
With impact player, it is getting difficult each and every day: Pant
Congress in K’taka to stage protest on Apr 28 against ‘paltry’ drought relief given by Centre
McGurk, Stubbs rock as DC beat MI by 10 runs
‘Shaurya Smarak’ of three fallen Army officers unveiled in Jammu
BJP drops Poonam Mahajan, picks 26/11 prosecutor Ujjwal Nikam from Mumbai North Central seat